[1] |
Alves R, Grimalt R. A review of platelet-rich plasma: history, biology, mechanism of action, and classification[J]. Skin Appendage Disord, 2018, 4(1): 18-24. DOI: 10.1159/000477353.
|
[2] |
Wu PI, Diaz R, Borg-Stein J. Platelet-rich plasma[J]. Phys Med Rehabil Clin N Am, 2016, 27(4): 825-53. DOI: 10.1016/j.pmr.2016.06.002.
|
[3] |
Everts P, Onishi K, Jayaram P, et al. Platelet-rich plasma: new performance understandings and therapeutic considerations in 2020[J]. Int J Mol Sci, 2020, 21(20): 7794. DOI: 10.3390/ijms21207794.
|
[4] |
Girijala RL, Riahi RR, Cohen PR. Platelet-rich plasma for androgenic alopecia treatment: a comprehensive review[J]. Dermatol Online J, 2018, 24(7): 13030/qt8s43026c.
|
[5] |
Chen P, Huang L, Ma Y, et al. Intra-articular platelet-rich plasma injection for knee osteoarthritis: a summary of Meta-analyses[J]. J Orthop Surg Res, 2019, 14(1): 385. DOI: 10.1186/s13018-019-1363-y.
|
[6] |
Grassi A, Napoli F, Romandini I, et al. Is platelet-rich plasma (PRP) effective in the treatment of acute muscle injuries? A systematic review and Meta-analysis[J]. Sports Med, 2018, 48(4): 971-989. DOI: 10.1007/s40279-018-0860-1.
|
[7] |
Zhang M, Park G, Zhou B, et al. Applications and efficacy of platelet-rich plasma in dermatology: a clinical review[J]. J Cosmet Dermatol, 2018, 17(5): 660-665. DOI: 10.1111/jocd.12673.
|
[8] |
Riestra AC, Alonso-Herreros JM, Merayo-Lloves J. Platelet rich plasma in ocular surface[J]. Arch Soc Esp Oftalmol, 2016, 91(10): 475-490. DOI: 10.1016/j.oftal.2016.03.001.
|
[9] |
Knezevic NN, Candido KD, Desai R, et al. Is platelet-rich plasma a future therapy in pain management?[J]. Med Clin North Am, 2016, 100(1): 199-217. DOI: 10.1016/j.mcna.2015.08.014.
|
[10] |
|
[11] |
Dohan Ehrenfest DM, Rasmusson L, Albrektsson T. Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF)[J]. Trends Biotechnol, 2009, 27(3): 158-167. DOI: 10.1016/j.tibtech.2008.11.009.
|
[12] |
Kasius A, Smit JG, Torrance HL, et al. Endometrial thickness and pregnancy rates after IVF: a systematic review and Meta-analysis[J]. Hum Reprod Update, 2014, 20(4): 530-541. DOI: 10.1093/humupd/dmu011.
|
[13] |
Maleki-Hajiagha A, Razavi M, Rouholamin S, et al. Intrauterine infusion of autologous platelet-rich plasma in women undergoing assisted reproduction: a systematic review and Meta-analysis[J]. J Reprod Immunol, 2020, 137: 103078. DOI: 10.1016/j.jri.2019.103078.
|
[14] |
李晓凤,王芳,陶丽梅,等. 宫腔灌注富血小板血浆对薄型子宫内膜不孕患者疗效的Meta分析[J]. 实用妇产科杂志,2020, 36(7): 545-549.
|
[15] |
Nazari L, Salehpour S, Hoseini S, et al. Effects of autologous platelet-rich plasma on endometrial expansion in patients undergoing frozen-thawed embryo transfer: a double-blind RCT[J]. Int J Reprod Biomed, 2019, 17(6): 443-448. DOI: 10.18502/ijrm.v17i6.4816.
|
[16] |
Eftekhar M, Neghab N, Naghshineh E, et al. Can autologous platelet rich plasma expand endometrial thickness and improve pregnancy rate during frozen-thawed embryo transfer cycle? A randomized clinical trial[J]. Taiwan J Obstet Gynecol, 2018, 57(6): 810-813. DOI: 10.1016/j.tjog.2018.10.007.
|
[17] |
Chang Y, Li J, Wei LN, et al. Autologous platelet-rich plasma infusion improves clinical pregnancy rate in frozen embryo transfer cycles for women with thin endometrium[J]. Medicine (Baltimore), 2019, 98(3): e14062. DOI: 10.1097/md.0000000000014062.
|
[18] |
Agarwal M, Mettler L, Jain S, et al. Management of a thin endometrium by hysteroscopic instillation of platelet-rich plasma into the endomyometrial junction: a pilot study[J]. J Clin Med, 2020, 9(9): 2795. DOI: 10.3390/jcm9092795.
|
[19] |
AAGL Elevating Gynecologic Surgery. AAGL practice report: practice guidelines on intrauterine adhesions developed in collaboration with the European Society of Gynaecological Endoscopy (ESGE)[J]. Gynecol Surg, 2017, 14(1): 6. DOI: 10.1186/s10397-017-1007-3.
|
[20] |
Di Spiezio Sardo A, Calagna G, Scognamiglio M, et al. Prevention of intrauterine post-surgical adhesions in hysteroscopy. A systematic review[J]. Eur J Obstet Gynecol Reprod Biol, 2016, 203: 182-192. DOI: 10.1016/j.ejogrb.2016.05.050.
|
[21] |
Dreisler E, Kjer JJ. Asherman′s syndrome: current perspectives on diagnosis and management[J]. Int J Womens Health, 2019, 11: 191-198. DOI: 10.2147/ijwh.S165474.
|
[22] |
Jang HY, Myoung SM, Choe JM, et al. Effects of autologous platelet-rich plasma on regeneration of damaged endometrium in female rats[J]. Yonsei Med J, 2017, 58(6): 1195-1203. DOI: 10.3349/ymj.2017.58.6.1195.
|
[23] |
Kim JH, Park M, Paek JY, et al. Intrauterine infusion of human platelet-rich plasma improves endometrial regeneration and pregnancy outcomes in a murine model of Asherman′s syndrome[J]. Front Physiol, 2020, 11: 105. DOI: 10.3389/fphys.2020.00105.
|
[24] |
Marini MG, Perrini C, Esposti P, et al. Effects of platelet-rich plasma in a model of bovine endometrial inflammation in vitro[J]. Reprod Biol Endocrinol, 2016, 14(1): 58. DOI: 10.1186/s12958-016-0195-4.
|
[25] |
Zhang S, Li P, Yuan Z, et al. Platelet-rich plasma improves therapeutic effects of menstrual blood-derived stromal cells in rat model of intrauterine adhesion[J]. Stem Cell Res Ther, 2019, 10(1): 61. DOI: 10.1186/s13287-019-1155-7.
|
[26] |
Aghajanova L, Cedars MI, Huddleston HG. Platelet-rich plasma in the management of Asherman syndrome: case report[J]. J Assist Reprod Genet, 2018, 35(5): 771-775. DOI: 10.1007/s10815-018-1135-3.
|
[27] |
Torky AMMAE, Amer MIM, Ahmed MES, et al. The value of using platelet rich plasma after hysteroscopic analysis of severe intrauterine adhesions (a randomized controlled trial)[J]. Egypt J Hosp Med, 2018, 71(4): 2869-2874. DOI: 10.12816/0046137.
|
[28] |
Javaheri A, Kianfar K, Pourmasumi S, et al. Platelet-rich plasma in the management of Asherman′s syndrome: an RCT[J]. Int J Reprod Biomed, 2020, 18(2): 113-120. DOI: 10.18502/ijrm.v18i2.6423.
|
[29] |
Peng J, Li M, Zeng H, et al. Intrauterine infusion of platelet-rich plasma is a treatment method for patients with intrauterine adhesions after hysteroscopy[J]. Int J Gynaecol Obstet, 2020, 151(3): 362-365. DOI: 10.1002/ijgo.13353.
|
[30] |
|
[31] |
Gialeraki A, Valsami S, Pittaras T, et al. Oral contraceptives and HRT risk of thrombosis[J]. Clin Appl Thromb Hemost, 2017, 24(2): 217-225. DOI: 10.1177/1076029616683802.
|
[32] |
Rymer J, Brian K, Regan L. HRT and breast cancer risk[J]. BMJ, 2019, 367: l5928. DOI: 10.1136/bmj.l5928.
|
[33] |
Sheikhansari G, Aghebati-Maleki L, Nouri M, et al. Current approaches for the treatment of premature ovarian failure with stem cell therapy[J]. Biomed Pharmacother, 2018, 102: 254-262. DOI: 10.1016/j.biopha.2018.03.056.
|
[34] |
Pantos K, Nitsos N, Kokkali G, et al. Ovarian rejuvenation and folliculogenesis reactivation in peri-menopausal women after autologous platelet-rich plasma treatment[C]// Proceedings of the Abstracts, ESHRE 32nd Annual Meeting, 2016. Helsinki: ESHRE, 2016.
|
[35] |
Sills ES, Rickers NS, Li X, et al. First data on in vitro fertilization and blastocyst formation after intraovarian injection of calcium gluconate-activated autologous platelet rich plasma[J]. Gynecol Endocrinol, 2018, 34(9): 756-760. DOI: 10.1080/09513590.2018.1445219.
|
[36] |
Sfakianoudis K, Simopoulou M, Grigoriadis S, et al. Reactivating ovarian function through autologous platelet-rich plasma intraovarian infusion: pilot data on premature ovarian insufficiency, perimenopausal, menopausal, and poor responder women[J]. J Clin Med, 2020, 9(6): 1809. DOI: 10.3390/jcm9061809.
|
[37] |
Cakiroglu Y, Saltik A, Yuceturk A, et al. Effects of intraovarian injection of autologous platelet rich plasma on ovarian reserve and IVF outcome parameters in women with primary ovarian insufficiency[J]. Aging (Albany NY), 2020, 12(11): 10211-10222. DOI: 10.18632/aging.103403.
|
[38] |
Atkinson L, Martin F, Sturmey RG. Intraovarian injection of platelet-rich plasma in assisted reproduction: too much too soon?[J]. Hum Reprod, 2021, 36(7): 1737-1750. DOI: 10.1093/humrep/deab106.
|
[39] |
Sills ES, Wood SH. Autologous activated platelet-rich plasma injection into adult human ovary tissue: molecular mechanism, analysis, and discussion of reproductive response[J]. Biosci Rep, 2019, 39(6): BSR20190805. DOI: 10.1042/BSR20190805.
|
[40] |
Tehranian A, Esfehani-Mehr B, Pirjani R, et al. Application of autologous platelet-rich plasma (PRP) on wound healing after caesarean section in high-risk patients[J]. Iran Red Crescent Med J, 2016, 18(7): e34449. DOI: 10.5812/ircmj.34449.
|
[41] |
Morelli M, Rocca ML, Venturella R, et al. Adjuvant use of platelet gel for wound breakdown prevention in advanced vulvar cancer surgery: a retrospective study[J]. Int J Gynecol Cancer, 2013, 23(8): 1490-1494. DOI: 10.1097/IGC.0b013e3182a50517.
|
[42] |
Shirvan MK, Alamdari DH, Ghoreifi A. A novel method for iatrogenic vesicovaginal fistula treatment: autologous platelet rich plasma injection and platelet rich fibrin glue interposition[J]. J Urol, 2013, 189(6): 2125-2129. DOI: 10.1016/j.juro.2012.12.064.
|
[43] |
Streit-Cieckiewicz D, Futyma K, Miotla P, et al. Platelet-rich plasma as adjuvant therapy for recurrent vesicovaginal fistula: a prospective case series[J]. J Clin Med, 2019, 8(12): 2122. DOI: 10.3390/jcm8122122.
|
[44] |
Casabona F, Priano V, Vallerino V, et al. New surgical approach to lichen sclerosus of the vulva: the role of adipose-derived mesenchymal cells and platelet-rich plasma in tissue regeneration[J]. Plast Reconstr Surg, 2010, 126(4): 210e-211e. DOI: 10.1097/PRS.0b013e3181ea9386.
|
[45] |
Behnia-Willison F, Pour NR, Mohamadi B, et al. Use of platelet-rich plasma for vulvovaginal autoimmune conditions like lichen sclerosus[J]. Plast Reconstr Surg Glob Open, 2016, 4(11): e1124. DOI: 10.1097/gox.0000000000001124.
|
[46] |
Goldstein AT, Mitchell L, Govind V, et al. A randomized double-blind placebo-controlled trial of autologous platelet-rich plasma intradermal injections for the treatment of vulvar lichen sclerosus[J]. J Am Acad Dermatol, 2019, 80(6): 1788-1789. DOI: 10.1016/j.jaad.2018.12.060.
|
[47] |
Gorlero F, Glorio M, Lorenzi P, et al. New approach in vaginal prolapse repair: mini-invasive surgery associated with application of platelet-rich fibrin[J]. Int Urogynecol J, 2012, 23(6): 715-722. DOI: 10.1007/s00192-012-1667-5.
|
[48] |
Medel S, Alarab M, Kufaishi H, et al. Attachment of primary vaginal fibroblasts to absorbable and nonabsorbable implant materials coated with platelet-rich plasma: potential application in pelvic organ prolapse surgery[J]. Female Pelvic Med Reconstr Surg, 2015, 21(4): 190-197. DOI: 10.1097/spv.0000000000000178.
|
[49] |
Behnia-Willison F, Nguyen TTT, Norbury AJ, et al. Promising impact of platelet rich plasma and carbon dioxide laser for stress urinary incontinence[J]. Eur J Obstet Gynecol Reprod Biol X, 2020, 5: 100099. DOI: 10.1016/j.eurox.2019.100099.
|
[50] |
Nikolopoulos KI, Pergialiotis V, Perrea D, et al. Restoration of the pubourethral ligament with platelet rich plasma for the treatment of stress urinary incontinence[J]. Med Hypotheses, 2016, 90: 29-31. DOI: 10.1016/j.mehy.2016.02.019.
|
[51] |
Hersant B, Sidahmed-Mezi M, Belkacemi Y, et al. Efficacy of injecting platelet concentrate combined with hyaluronic acid for the treatment of vulvovaginal atrophy in postmenopausal women with history of breast cancer: a phase 2 pilot study[J]. Menopause, 2018, 25(10): 1124-1130. DOI: 10.1097/gme.0000000000001122.
|